OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Altered receptor binding, antibody evasion and retention of T cell recognition by the SARS-CoV-2 XBB.1.5 spike protein
Dhiraj Mannar, James W. Saville, Chad Poloni, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8

Showing 8 citing articles:

A comprehensive overview of recent advances in generative models for antibodies
Fanxu Meng, Na Zhou, Hu Guangchun, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 2648-2660
Open Access | Times Cited: 1

Cryo-electron microscopy in the study of virus entry and infection
Moumita Dutta, Priyamvada Acharya
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 1

Molecular and structural insights into SARS-CoV-2 evolution: from BA.2 to XBB subvariants
Hisano Yajima, Tomo Nomai, Kaho Okumura, et al.
mBio (2024) Vol. 15, Iss. 10
Open Access | Times Cited: 1

Si–rhodamine derivative with a large stokes shift for ELISA-based detection of SARS-CoV-2
Yanhong Liu, Hong Zhang, Kang‐Kang Yu, et al.
Sensors & Diagnostics (2024) Vol. 3, Iss. 5, pp. 822-826
Open Access

Profiling serum immunodominance following SARS-CoV-2 primary and breakthrough infection reveals distinct variant-specific epitope usage and immune imprinting
Jeffrey Seow, George Jefferson, Michael D. Keegan, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 11, pp. e1012724-e1012724
Open Access

A Spike-Accum® Bioconjugate Protein Vaccine Confers Potent SARS-COV-2-Specific Immunity
Jean Pierre Bikorimana, Nathanael A. Caveney, Nehme El‐Hachem, et al.
(2024)
Closed Access

Page 1

Scroll to top